India Urges Reluctant MNCs To Launch New Drugs In Country
This article was originally published in PharmAsia News
The Indian government is urging multinational pharmaceutical companies to launch their new drugs in India, most of them for the first time since 1995. Some MNCs stopped marketing their drugs in India because of a fear that local generics makers would make illegal copies of MNC drugs. Some drug industry insiders believe India would have to improve its patent laws before MNCs could be enticed to launch their new drugs in the country. They point to Roche and Pfizer, who have lawsuits pending in court, claiming infringement of their patents by generic companies copying recently launched products. (Click here for more
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.